Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jinghua Li
Observed name:
JingHua Li
Institution:
Beijing University of Chinese Medicine
Observed institution:
Beijing University of Chinese Medicine
ORCID:
0000-0002-6755-955X
Observed ORCID:
0000-0002-6755-955X
OpenAlex ID:
A5091167951
Xingxiao pills suppresses lung adenocarcinoma progression by modulating lipid metabolism and inhibiting the PLA2G4A-GLI1-SOX2 Axis
2025
·
Xueni Fang
, JingHua Li
, et al.
·
Phytomedicine
·
14
Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
·
Cancer Research
·
7
Data from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
·
1
Supplementary Figure S8 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Table 1 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Figure S9 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Table 5 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Table 2 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Table 4 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Table 6 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Table 3 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Figure S3 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Data S7 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Figure S13 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Figure S2 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Data S4 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Figure S15 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Figure S17 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Figure S11 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Figure S7 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Figure S19 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Figure S16 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Figure S4 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
PDF
Supplementary Data S3 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Supplementary Data S1 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
2025
·
Guofei Cui
, Yi Zhou
, et al.
Show more works
View as search
Works count:
35
Citation count:
22
H-index:
2
I10-index:
1
Year
Topic
Type